Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 65862-191

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 65862-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

Label for Cyclobenzaprine Hydrochloride Tablets, USP 5 mg, film-coated tablets in a bulk package of 100 tablets. The label indicates the product is Rx only, distributed by Aurobindo Pharma USA, Inc., made in India, with storage instructions and usual adult dosage information included.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

Label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates a package of 100 tablets, with dosing, storage, and handling information. It includes the NDC 65862-191-01 and distributor details for Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical structure diagram of Cyclobenzaprine Hydrochloride, showing the molecular arrangement of rings and side chains including the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.